Racial Disparities and Mental Health Effects Within Prostate Cancer.
health disparities
mental health
prostate cancer
racial disparities
Journal
Health psychology research
ISSN: 2420-8124
Titre abrégé: Health Psychol Res
Pays: United States
ID NLM: 101633445
Informations de publication
Date de publication:
2022
2022
Historique:
entrez:
25
11
2022
pubmed:
26
11
2022
medline:
26
11
2022
Statut:
epublish
Résumé
Disparities in prostate cancer (PCa) exist at all stages: screening, diagnosis, treatment, outcomes, and mortality. Although there are a multitude of complex biological (e.g., genetics, age at diagnosis, PSA levels, Gleason score) and nonbiological (e.g., socioeconomic status, education level, health literacy) factors that contribute to PCa disparities, nonbiological factors may play a more significant role. One understudied aspect influencing PCa patients is mental health related to the quality of life. Overall, PCa patients report poorer mental health than non-PCa patients and have a higher incidence of depression and anxiety. Racial disparities in mental health, specifically in PCa patients, and how poor mental health impacts overall PCa outcomes require further study.
Identifiants
pubmed: 36425236
doi: 10.52965/001c.39654
pii: 39654
pmc: PMC9680850
doi:
Types de publication
Journal Article
Langues
eng
Pagination
39654Références
Oncology. 2021;99(4):260-270
pubmed: 33486485
BMJ Open. 2019 Jan 24;9(1):e026809
pubmed: 30679301
Cancer. 2017 Nov 1;123(21):4199-4206
pubmed: 28654204
Psychiatry Res. 2019 Oct;280:112499
pubmed: 31398576
Cancer Res. 2018 May 1;78(9):2432-2443
pubmed: 29438991
LGBT Health. 2019 Aug/Sep;6(6):271-288
pubmed: 31314662
Int Urol Nephrol. 2019 Aug;51(8):1343-1348
pubmed: 31049779
Am J Mens Health. 2021 May-Jun;15(3):15579883211023699
pubmed: 34142615
J Urol. 2021 Jul;206(1):69-79
pubmed: 33683934
J Cancer Educ. 2015 Mar;30(1):138-44
pubmed: 25015841
Cancer. 2017 Nov 15;123(22):4449-4457
pubmed: 28727136
J Urol. 2022 May;207(5):1029-1037
pubmed: 34978488
Oncotarget. 2017 Mar 28;8(13):20802-20812
pubmed: 28160549
Transl Behav Med. 2019 Jul 16;9(4):629-637
pubmed: 30285186
Prostate Cancer Prostatic Dis. 2021 Dec;24(4):1129-1136
pubmed: 33947975
J Cancer. 2016 Jul 05;7(11):1452-64
pubmed: 27471561
J Psychosom Res. 2019 Sep;124:109760
pubmed: 31443804
Eur Urol. 2018 Mar;73(3):445-451
pubmed: 28778619
Transl Androl Urol. 2017 Jun;6(3):566-579
pubmed: 28725600
Urol Oncol. 2017 Aug;35(8):531.e1-531.e7
pubmed: 28457651
Cancer. 2022 Jan 15;128(2):344-352
pubmed: 34550601
Prostate Cancer Prostatic Dis. 2019 Mar;22(1):125-136
pubmed: 30171227
J Urol. 2017 Mar;197(3 Pt 1):627-631
pubmed: 27582435
BJU Int. 2016 Jun;117(6B):E10-9
pubmed: 25818406
J Natl Cancer Inst. 2021 Oct 1;113(10):1343-1351
pubmed: 33892497
J Clin Oncol. 2010 Sep 1;28(25):3958-64
pubmed: 20679621
Prostate Cancer Prostatic Dis. 2015 Jun;18(2):104-9
pubmed: 25582624
Eur Urol. 2022 Oct;82(4):341-351
pubmed: 35367082
BMJ Open. 2014 Mar 13;4(3):e003901
pubmed: 24625637
Cancer Epidemiol Biomarkers Prev. 2016 Mar;25(3):547-54
pubmed: 26809276
Clin Genitourin Cancer. 2014 Oct;12(5):e189-95
pubmed: 24861952
Int J Cancer. 2018 Jun 15;142(12):2478-2484
pubmed: 29363113
Cancer Lett. 2022 Apr 10;531:71-82
pubmed: 35122875
J Urol. 2017 Feb;197(2):342-349
pubmed: 27596691
Clin Genitourin Cancer. 2019 Oct;17(5):e1054-e1059
pubmed: 31303559
JAMA Oncol. 2016 Jan;2(1):85-93
pubmed: 26502115
Prostate Cancer Prostatic Dis. 2021 Dec;24(4):1093-1102
pubmed: 33941865
J Urol. 2021 Feb;205(2):426-433
pubmed: 33226309
Am J Hosp Palliat Care. 2017 Jul;34(6):497-504
pubmed: 26922817
J Natl Compr Canc Netw. 2015 Sep;13(9):1131-8
pubmed: 26358797
Urology. 2017 Jan;99:76-83
pubmed: 27667157
Cancer Nurs. 2018 Jan/Feb;41(1):E1-E8
pubmed: 27442211
Urology. 2016 Sep;95:88-94
pubmed: 27318264
Psychooncology. 2006 Feb;15(2):121-31
pubmed: 15880458
Urology. 2022 May;163:107-111
pubmed: 34418408
Curr Oncol. 2021 Oct 02;28(5):3900-3917
pubmed: 34677251
Am J Clin Exp Urol. 2017 Nov 09;5(3):34-48
pubmed: 29181436
Urology. 2014 Dec;84(6):1434-41
pubmed: 25432835
Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2150-9
pubmed: 21784953
JAMA Oncol. 2019 Jul 1;5(7):975-983
pubmed: 31120534
JAMA. 2019 Feb 19;321(7):704-706
pubmed: 30743264
Cancer Med. 2020 Jun;9(12):4467-4473
pubmed: 32329252
Prostate Cancer Prostatic Dis. 2020 Dec;23(4):567-572
pubmed: 32152436
Curr Urol Rep. 2017 Aug 14;18(10):81
pubmed: 28808871
J Oncol Pharm Pract. 2020 Dec;26(8):1997-2010
pubmed: 32972301
Urology. 2010 Nov;76(5):1224-30
pubmed: 20817270
Cancer. 2019 Oct 1;125(19):3418-3427
pubmed: 31246284
J Health Care Poor Underserved. 2005 May;16(2):375-90
pubmed: 15937399
Cancer Nurs. 2012 Sep-Oct;35(5):355-64
pubmed: 22495496
Eur Urol Focus. 2020 Nov 15;6(6):1165-1167
pubmed: 32680828
Support Care Cancer. 2013 May;21(5):1303-11
pubmed: 23292697
Cochrane Database Syst Rev. 2012 Aug 15;(8):CD008465
pubmed: 22895974
Asia Pac J Clin Oncol. 2020 Apr;16(2):e125-e130
pubmed: 31069946
Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):891-7
pubmed: 23515145
Ann Oncol. 2013 Sep;24(9):2274-8
pubmed: 23813928
J Racial Ethn Health Disparities. 2018 Feb;5(1):104-110
pubmed: 28205153
Psychooncology. 2018 Oct;27(10):2374-2381
pubmed: 29959807
Eur Urol. 2013 Jul;64(1):30-6
pubmed: 23357351
J Racial Ethn Health Disparities. 2019 Apr;6(2):401-408
pubmed: 30506310
Dis Markers. 2020 Jun 18;2020:3904947
pubmed: 32655718
Front Oncol. 2022 Apr 13;12:833197
pubmed: 35494011
Prostate Int. 2014 Sep;2(3):133-9
pubmed: 25325025
J Clin Oncol. 2013 Aug 20;31(24):2991-7
pubmed: 23775960
Urology. 2020 Feb;136:9-18
pubmed: 31770548